Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mohadeseh Haji Abdolvahab"'
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Targeted drug delivery is one of the attractive ways in which cancer treatment can significantly reduce side effects. In the last two decades, the use of antibodies as a tool for accurate detection of cancer has been noted. On the other hand
Externí odkaz:
https://doaj.org/article/36054b83344d4ff59b8b241bbe0d662b
Autor:
Mohadeseh Haji Abdolvahab, Mojdeh Safari, Farkhonde Hasannejad, Nika Asefi, Alireza Salimi, Mahboobeh Nazari
Publikováno v:
Journal of Biological Engineering, Vol 18, Iss 1, Pp 1-13 (2024)
Abstract The sequence of a carboxy-terminal of the β-lactam sensor-transducer protein (BlaR-CTD) from Bacillus licheniformis ATCC14580 was extracted from US7745193B2 patent and expressed in E. coli using pColdI vector as a soluble His-tag recombinan
Externí odkaz:
https://doaj.org/article/b5901bfb2d684269bd2e0cc02b3fa42e
Publikováno v:
Informatics in Medicine Unlocked, Vol 32, Iss , Pp 101036- (2022)
The ability of recombinant human interferon beta-1b (IFNβ-1b) to elicit the production of anti-IFNβ-1b antibodies becomes a significant issue for interferon therapy in patients. Mitigating the immunogenicity issues requires understanding the stimul
Externí odkaz:
https://doaj.org/article/f9ec7820bd6c49b1bbd7e0c9b5ba0e8d
Autor:
Zohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, Ali Hussein Mer, Seyyed Amirreza Saghi, Mohadeseh Haji Abdolvahab, Nader Bagheri, Anna Meyfour, Ameneh Jafari, Saeed Jahandideh, Tohid Gharibi, Zahra Amirkhani, Hamed Delam, Noushin Mashatan, Hosein Shahsavarani, Meghdad Abdollahpour-Alitappeh
Publikováno v:
Molecular Therapy.
Autor:
Mohsen Nakhaie, Nasir Arefinia, Javad Charostad, Davood Bashash, Mohadeseh Haji Abdolvahab, Mohammad Zarei
Publikováno v:
Reviews in Medical Virology. 33
The multi-country outbreak of monkeypox virus (MPXV) infection, while the coronavirus disease 2019 pandemic is still an ongoing issue, has caused a new challenge. The re-emergence of MPXV and the rising incidence in non-endemic countries is turning i
Autor:
Keyvan Majidzadeh-A, Leila Farahmand, Neda Jalili, Shima Moradi-Kalbolandi, Mohadeseh Haji Abdolvahab
Publikováno v:
Probiotics and Antimicrobial Proteins
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), causing the 2019 novel coronavirus disease (COVID-19), was introduced by WHO (World Health Organization) as "pandemic" in March 2020. According to WHO, thus far (23 November 2020) 58,425,68
Autor:
Ahmad Fazeli, Mehrdad Behmanesh, Mohadeseh Haji Abdolvahab, Seyed Shahriar Arab, Hanka Venselaar
Publikováno v:
International Journal of Peptide Research and Therapeutics. 26:1353-1361
Interferon beta (IFNβ) is naturally occurring cytokine made and secreted by immune cells in response to stimuli. Non-glycosylated interferon beta Ser 17 mutein (IFNβ-Ser17) is widely used for treatment of active relapsing multiple sclerosis. Despit
Autor:
Keivan Majidzadeh-A, Mohadeseh Haji Abdolvahab, Shima Moradi-Kalbolandi, Mohammad Zarei, Leila Farahmand, Deepanwita Bose
Publikováno v:
International Immunopharmacology
Highlights • COVID-19 disease, the recently public health crises in the world, is emerged by spreading the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). • This virus can produce from weak to severe respiratory diseases including a
Autor:
Mohammad Zarei, Keivan Majidzadeh-A, Leila Farahmand, Behrad Darvishi, Mohadeseh Haji Abdolvahab
Publikováno v:
Immunotherapy. 12(11)
Interferons (IFNs) are a group of signaling cytokines, secreted by host cells to induce protection against various disorders. IFNs can directly impact on tumor cells or indirectly induce the immune system to protect host cells. The expression levels